Farms.com Home   Ag Industry News

”Roundup is not a carcinogen,” says Monsanto CEO

Part 2 of Hugh Grant’s interview with Here & Now

By Diego Flammini
Assistant Editor, North American Content
Farms.com

On Thursday, Monsanto CEO Hugh Grant joined Here & Now in Boston for a two-part interview to discuss various issues in the ag industry.

In Part 1, Grant discussed GMOs, strategies to make agriculture more sustainable and consumer concerns with host Jeremy Hobson.

Part 2 sees Grant touch on a variety of topics including Monsanto and Roundup’s places in the global landscape.

When it comes to those who believe Roundup is a cancer-causing product, Grant’s answer was direct.

“Roundup is not a carcinogen,” he said during the interview.

Grant said the product has been tested and reviewed nearly each of its 40-year existence. According to Grant, Europe’s review of the product was “glowing,” Canada is currently conducting its review and the United States will conduct its own as well.

“I’ve absolutely no concerns about the safety of the product,” he said.

Despite being the head of a company that makes chemical products, Grant says the future of agriculture will depend on a cooperative effort from organic and conventional farmers, especially as infrastructure continues to develop.

“As urbanization increases, we’re going to need all kinds of agriculture,” he said. “It’s framed somehow as big versus little, or organic verses conventional. We’re going to need everybody at the table.”


Trending Video

2026 USDA Acreage Fireworks Next Week? + RVO’s Old new

Video: 2026 USDA Acreage Fireworks Next Week? + RVO’s Old news


Next week’s USDA reports (acreage/stocks) could be a surprise/market moving. RVO’s (new blending biofuel requirements) were as expected with no big surprises and already baked into futures. E15 summer waiver just simply good optics. Markets are skeptical that the war in Iran ends soon with no diplomatic off ramp. The Trump/Xi meeting in China now May 14 – 15. March 1 USDA hogs and Pigs report was friendly/bullish + CFTC and more.